UPDATE: Cantor Fitzgerald Initiates Coverage on Zeltiq Aesthetics as Momentum Story Shows Little Sign of Cooling Off

In a report published Friday, Cantor Fitzgerald analyst Jeremy Feffer initiated coverage on Zeltiq Aesthetics (NASDAQ: ZLTQ ) with a Buy rating and $20.00 price target. In the report, Cantor Fitzgerald noted, “We are initiating coverage of ZLTQ with a BUY rating and a $20 price target. Despite the substantial